Most importantly, the Cancer Genome Atlas (TCGA) data demonstrate that SPOP‐mutated prostate cancers exhibit the highest AR activity among all molecular subtypes of prostate cancer examined (Cancer Genome Atlas Research Network, 2015). This evidence concerns the gene SPOP and prostate cancer.